Arena Pharmaceuticals, Inc. (ARNA) has market cap of $2125.29 million and holds 49.37 million shares outstanding. The stock accomplished trade value at $43.05 with 0.44% and traded volume 193082 shares in recent trading period versus to an average volume of 634.7K. The stock demonstrated move of -1.22% in previous 5 days graph. Its quarterly performance stands with the percentage of 10.02% while its year to date performance showed change of 10.53%.
Arena Pharmaceuticals, Inc. (ARNA) publicized the closing of the global license agreement with United Therapeutics Corporation (Nasdaq: UTHR) for the Arena-discovered, Phase 3 investigational drug candidate ralinepag, a next-generation, oral, selective and potent prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension (PAH). The global license agreement for ralinepag was announced on November 15, 2018.
Upon closing on January 24, 2019, United Therapeutics paid a non-refundable upfront cash payment of $800 million to Arena. In addition, Arena is eligible to receive potential milestone payments totaling up to $400 million based on the achievement of certain regulatory events and low double-digit tiered royalties on annual net sales of ralinepag.
The stock has monthly performance of 20.39% while its yearly performance remained at 14.25%. Its return on investment (ROI) for the last 12 months was -34.20% and its return on equity (ROE) of -23.80% while return on assets (ROA) is at -19.70%. The Company has an insider ownership of 0.16% and institutional ownership remained 84.40%.
Category – Business
Billy Gonzalez holds a postgraduate degree in Software Engineering from Canada. ‘The stock market is filled with individuals who know the price of everything, but the value of nothing.’ Billy is a share market expert, being personally invested for over 6 years. He believes the most valuable nugget of wisdom for new investors is a quote from Phillip Fisher. He has been writing his entire life, and while he has made a career of business and finance reporting, he still enjoys writing short stories and poetry.
Billy has worked as financial analyst until his retirement. He is a well-known research director and portfolio manager for more than 5 years. After many years in the market, he dedicated all his time to write articles highlighting different financial problems.
Address: 17927 East Mercer Drive, Aurora, CO 80013, USA
Email: [email protected]
Zip code: 80013
Contact # 303-338-4412